Global Continuous Renal Replacement Therapy Market Insights Forecasts to 2030

• The Continuous Renal Replacement Therapy Market was valued at USD 1.3 Billion in 2021.
• The Market is growing at a CAGR of 8.91% from 2022 to 2030
• The Global Continuous Renal Replacement Therapy Market is expected to reach USD 2.7 Billion by 2030
• Asia Pacific is expected to grow the fastest during the forecast period

Get more details on this report -

Request Free Sample PDF

 

The Global Continuous Renal Replacement Therapy Market is expected to reach USD 2.7 Billion by 2030, at a CAGR of 8.91% during the forecast period 2022 to 2030.

 

Market Overview

Continuous renal replacement treatment (CRRT) is a slow and painless technique for purifying extracorporeal blood. It is often carried out over a period of 24 to several days while gently removing extra fluid and uremic poisons. The physiological concepts of diffusion, ultrafiltration, convection, and adsorption are typically used to underpin this approach.

 

Report Coverage

This research report categorizes the market for Continuous Renal Replacement Therapy market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Continuous Renal Replacement Therapy market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the Continuous Renal Replacement Therapy market.

 

    

Driving Factors

The prevalence of acute kidney injury (AKI), sepsis, the rapid expansion of hospitals and urgent care facilities, the number of hospital admissions, and the regular product launches by major market players are only a few of the variables influencing the demand for CRRT and driving market expansion. Also, the clinical benefits of continuous renal replacement therapy (CRRT) over intermittent blood purifying methods will play a significant role in the market's expansion. The growth of the market for continuous renal replacement treatment is also being driven by rising urbanisation and an ageing population. The increased prevalence of chronic kidney disease, which is a major risk factor for diabetes, hypertension, cardiovascular disease, and the inflammatory kidney disease known as glomerulonephritis, is one of the main factors propelling the growth of the continuous expansion renal replacement therapy market.

 

Restraining Factors

The market's growth rate will be significantly hampered by the rising number of CRRT-related issues. To start CRRT, a large-bore central venous catheter must be inserted and may need to be left in place for a lengthy amount of time. Catheter insertion is reported to result in vascular or visceral damage, bleeding, pneumothorax, hem thorax, and the creation of an arteria-venous fistula. Venous thrombosis and stenosis have been connected to long-term catheter use. The market's growth rate will also be slowed down during the projection period by an unfavourable reimbursement scenario and a lack of awareness.

 

Market Segmentation

• In 2021, the Consumables segment is witnessing the significant growth over the forecast period.

On the basis of product, the global continuous renal replacement therapy market is segmented into system, consumables. Among these, the consumables segment is witnessing the significant growth over the forecast period. CRRT consumables include hemofilters, line sets, fluid/dialysate, and accessories. Hemofilters, also referred to as artificial kidneys, are constructed from a hollow-fiber membrane that controls the amount of fluid and solute evacuated. Businesses like Baxter and Fresenius provide a range of consumables across modalities for individuals with severe renal diseases. Although being cheap, these products are more commonly bought than those in other categories. The consumables segment is anticipated to grow as a result.

 

For instance, in April 2020, Baxter International Inc. presented updates on its initiatives to increase the global supply of dialysis, which is urgently needed. The demand for a variety of acute dialysis products is up to five times higher than historical levels as a result of an extraordinary increase in COVID-19 patients requiring Continuous Renal Replacement Therapy (CRRT). Additionally, businesses are maximising consumables like fluids and setting capacity and supply to meet historically high spikes in demand for their acute dialysis products in Europe and the United States, which is expected to propel market growth in the near future. Companies are also continuing to work with partners and governments around the world to address these issues.

 

• In 2021, the Continuous Venovenous Hemofiltration (CVVH) dominates the market with the largest market share over the forecast period.

The market for continuous renal replacement therapy was dominated by the Continuous Venovenous Hemofiltration (CVVH) segment, which generated revenue. The CVVH segment is expected to advance over the projection period due to the increased occurrence of fluid overload cases, which are frequently seen in patients with acute renal injury in critical care units. Combining hemodialysis and hemofiltration techniques, CVVHDF uses a highly effective hemodiafilter to remove both fluid and solute. The most common form of CRRT for AKI in many countries involves the complete removal and restoration of fluid and solute from the blood. Until CVVHDF was introduced in 2008 and took over as the main CRRT treatment mode, CVVH was the main CRRT therapy modality. Because CVVHDF has a greater survival rate than other CRRT modalities, the market for it is currently expected to grow significantly during the projected period.

 

Regional Segment Analysis of the Continuous Renal Replacement Therapy Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is dominating the market with the largest market share over the forecast period.

Get more details on this report -

Request Free Sample PDF

 

Among all other regions, North America is dominating the market with the largest market share over the forecast period. The rising prevalence of the geriatric population is a significant factor that is anticipated to support market expansion in this area. Alternative and improved approaches are being applied more strictly as the region's kidney diseases diagnosis rate rises. Also, it is thought that the largest contributing factors to the rise of numerous lifestyle-related ailments such kidney dysfunction, hypertension, and diabetes are the rising prevalence of sedentary lifestyles and bad eating patterns. For instance, the Chronic Kidney Disease (CKD) market is anticipated to increase in North America in 2021, when the U.S. Department of Health and Human Services estimates that around 37.0 million Americans, or more than one in seven adults, may have CKD.

 

Recent Developments

• In March 2021, B. Braun Avitum AG, a producer of pharmaceutical and medical device services and products, has announced the launch of a global co-marketing agreement with B. Braun's most recent OMNIset Plus bloodline set (set version 3.0 or higher) and Continuous Purification of Blood (OMNI) platform to support the use of CytoSorb.
• In June 2021, In order to provide education for healthcare professionals in critical care, renal care, and treatment strategies, Fresenius Medical Care opened a training centre in Korea.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global Continuous Renal Replacement Therapy market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Fresenius Medical Care
• Baxter International
• Toray Industries Inc.
• SWS Hemodialysis Care
• Nipro Corporation
• Ningbo Tianyi Medical Devices
• NIKKISO Co. Ltd
• Medtronic plc
• Medites Pharma spol. s.r.o
• Medical Components Inc.
• Medica S.p.A
• Infomed SA
• Cytosorbents
• Chongqing Shanwaishan Science and Technology
• B. Braun Melsungen Ag
• Asahi Kasei Corporation
• Anjue Medical Equipment Co. Ltd

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. Spherical Insights has segmented the global Continuous Renal Replacement Therapy market based on the below-mentioned segments:

 

Continuous Renal Replacement Therapy Market, By Product

·         System

·         Consumables

 

Continuous Renal Replacement Therapy Market, By Modality

·         Slow Continuous Ultra-Filtration (SCUF)

 

Continuous Renal Replacement Therapy Market, Regional Analysis

·         North America

o    US

o    Canada

o    Mexico

·         Europe

o    Germany

o    Uk

o    France

o    Italy

o    Spain

o    Russia

o    Rest of Europe

·         Asia Pacific

o    China

o    Japan

o    India

o    South Korea

o    Australia

o    Rest of Asia Pacific

·         South America

o    Brazil

o    Argentina

o    Rest of South America

·         Middle East & Africa

o    UAE

o    Saudi Arabia

o    Qatar

o    South Africa

o    Rest of Middle East & Africa